Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.

Article  PubMed  PubMed Central  Google Scholar 

Hong CM, Jeong YJ, Kim HW, Ahn BC. KSNM60 in Nuclear Endocrinology: from the Beginning to the Future. Nucl Med Mol Imaging. 2022;56:17–28.

Article  PubMed  PubMed Central  Google Scholar 

Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892–9.

Article  CAS  PubMed  Google Scholar 

Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 2013;179:361–82.

Article  CAS  PubMed  Google Scholar 

Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res. 2007;168:1–64.

Article  CAS  PubMed  Google Scholar 

Kim S, Bang JI, Boo D, Kim B, Choi IY, Ko S, et al. Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics. Eur J Nucl Med Mol Imaging. 2022;49:3547–56.

Article  CAS  PubMed  Google Scholar 

Hong CM, Shin JY, Kim BI, Song HC, Yoon JK, Won KS, et al. Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study. Eur J Nucl Med Mol Imaging. 2022;49:1661–70.

Article  PubMed  Google Scholar 

Seo GH, Kong KA, Kim BS, Kang SY, Moon BS, Yoon HJ, et al. Radioactive Iodine Treatment for Children and Young Adults with Thyroid Cancer in South Korea: A Population-based Study. J Clin Endocrinol Metab. 2021;106:e2580–8.

Article  PubMed  Google Scholar 

Yu CY, Saeed O, Goldberg AS, Farooq S, Fazelzad R, Goldstein DP, et al. A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer. Thyroid. 2018;28:1662–73.

Article  CAS  PubMed  Google Scholar 

Mei X, Yao X, Feng F, Cheng W, Wang H. Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients. BMC Cancer. 2021;21:543.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid. 2009;19:451–7.

Article  CAS  PubMed  Google Scholar 

Goldman MB, Maloof F, Monson RR, Aschengrau A, Cooper DS, Ridgway EC. Radioactive iodine therapy and breast cancer A follow-up study of hyperthyroid women. Am J Epidemiol. 1988;127:969–80.

Article  CAS  PubMed  Google Scholar 

Lin CY, Lin CL, Huang WS, Kao CH. Risk of Breast Cancer in Patients with Thyroid Cancer Receiving or Not Receiving 131I Treatment: A Nationwide Population-Based Cohort Study. J Nucl Med. 2016;57:685–90.

Article  CAS  PubMed  Google Scholar 

Ahn HY, Min HS, Yeo Y, Ma SH, Hwang Y, An JH, et al. Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer. J Clin Endocrinol Metab. 2015;100:3486–93.

Article  CAS  PubMed  Google Scholar 

Molenaar RJ, Sidana S, Radivoyevitch T, Advani AS, Gerds AT, Carraway HE, et al. Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer. J Clin Oncol. 2018;36:1831–9.

Article  CAS  PubMed  Google Scholar 

Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, et al. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study. J Natl Cancer Inst. 2016;108:djv314.

Article  PubMed  Google Scholar 

Seo GH, Cho YY, Chung JH, Kim SW. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide. Population-Based Study in Korea Thyroid. 2015;25:927–34.

PubMed  Google Scholar 

Kim KJ, Kim KJ, Choi J, Kim NH, Kim SG. Linear Association between Radioactive Iodine Dose and Second Primary Malignancy Risk in Thyroid Cancer. J Natl Cancer Inst. 2023;115(6):695–702.

Article  PubMed  Google Scholar 

Wu CC, Islam MM, Nguyen PA, Poly TN, Wang CH, Iqbal U, et al. Risk of cancer in long-term levothyroxine users: Retrospective population-based study. Cancer Sci. 2021;112:2533–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taieb D, Sebag F, Farman-Ara B, Portal T, Baumstarck-Barrau K, Fortanier C, et al. Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal. J Clin Endocrinol Metab. 2010;95(7):3283–90.

Article  CAS  PubMed  Google Scholar 

Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, et al. Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958–2009. Radiat Res. 2017;187:513–37.

Article  CAS  PubMed  PubMed Central  Google Scholar